Carnitine-dependent changes of metabolic fuel consumption during long-term treatment with valproic acid

This publication has 31 references indexed in Scilit:

• Muscle carnitine deficiency in patients using valproic acid
  The Journal of Pediatrics, 1991
• Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate
  Biochemical Medicine and Metabolic Biology, 1990
• Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy
  The Journal of Pediatrics, 1986
• Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid
  Biochemical and Biophysical Research Communications, 1985
• A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: Possible clinical significance
  Life Sciences, 1985
• Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes
  Biochemical and Biophysical Research Communications, 1983
• Carnitine deficiency and hyperammonemia associated with valproic acid therapy
  The Journal of Pediatrics, 1982
• Decreased serum carnitine in valproate induced Reye syndrome
  European Journal of Pediatrics, 1982
• Metabolic abnormalities observed in the rat after administration of sodium dipropylacetate
  Toxicology Letters, 1981
• The activation and oxidation of octanoate and palmitate by rat skeletal muscle mitochondria
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973